ARTICLE SUMMARY: Companies are being offered a new remedy by FDA when they feel the agency has gone too far in its 510(k) requests.
Regulatory & Reimbursement 2017 Regulatory Data Shows a Friendlier FDA November 27, 2017 Wendy Diller
Regulatory & Reimbursement Jeff Shuren, 10 Years in at CDRH, Wants More Space to Innovate June 27, 2019 David Filmore
Executive Interviews Expert Perspective: The Community Blog Checks In with Jeffrey Shuren October 16, 2018 Tracy Schaaf